Oncology Systems Limited Partners with Leo Cancer Care as UK and Ireland Distributor for Revolutionary Upright Radiotherapy Technology
6th January 2026
Strategic Distribution Agreement Will Bring Innovative Patient-Centric Cancer Treatment Solutions to the UK and Irish Healthcare Markets In the Future
Shrewsbury, UK, 6th January 2026 – Oncology Systems Limited (OSL), a leading provider of medical equipment and software to the NHS and private hospitals in the UK and Ireland, today announced it has signed an exclusive distribution agreement with Leo Cancer Care to bring the company’s groundbreaking upright radiotherapy technology to healthcare providers across the United Kingdom and Ireland in the coming years.
Leo Cancer Care is pioneering the transformation of radiation therapy through its innovative upright patient treatment systems, including the Marie® particle therapy platform and the recently announced Grace™ upright photon therapy system. The company’s “more human way to deliver radiation therapy” approach replaces traditional machine rotation with gentle patient rotation while maintaining a fixed radiation beam, offering improved patient comfort and growing research suggests that remaining upright, our natural posture may support more consistent anatomical positioning and organ stability compared with conventional supine treatments.
The distribution partnership will enable OSL to offer Leo Cancer Care’s groundbreaking systems to NHS trusts and private healthcare providers throughout the UK and Ireland, supporting the advancement of more patient-centric cancer care delivery.
Building on Decades of Expertise
“We are absolutely thrilled to partner with Leo Cancer Care and help bring this transformative upright radiotherapy technology to patients across the UK and Ireland,” said Alice Pavey, Managing Director of Oncology Systems Limited. “Leo’s innovative approach perfectly aligns with our commitment to advancing cancer care through cutting-edge technology solutions. Their patient-centric philosophy of making radiation therapy more comfortable and human represents the future of oncology treatment, and we’re excited to support healthcare providers in implementing these game-changing solutions.”
Alice continued, “The introduction of the future innovation Grace™ is particularly exciting as it brings the proven benefits of upright positioning to conventional photon therapy, making this revolutionary approach accessible to a much broader patient population. This partnership builds on our 26-year legacy of supporting radiotherapy departments with world-class solutions. Adding Leo’s comprehensive upright radiotherapy ecosystem to our offerings allows us to provide customers with a complete portfolio of innovative cancer treatment technologies.”
“We are thrilled to partner with OSL to bring Grace, the world’s most patient-centric upright radiotherapy platform, to clinicians and patients across the UK. This collaboration brings together OSL’s trusted national service infrastructure with Leo Cancer Care’s commitment to redefining how cancer treatment is delivered. Together, we will strive to make radiotherapy more accessible and comfortable, ensuring that every patient benefits from innovation designed for them”, said Mike Bauer, Chief Commercial Officer of Leo Cancer Care.
About Oncology Systems Limited
Founded in 1999 and based in Shrewsbury, UK, Oncology Systems Limited is a leading provider of medical equipment and software to the NHS and private hospitals in the UK and Ireland. OSL has established itself as a trusted partner to cancer treatment centres across the globe, with a focus on innovation, quality, and exceptional customer support.
About Leo Cancer Care
Leo Cancer Care is a global medical technology company dedicated to transforming cancer treatment through innovative upright radiotherapy solutions. Founded on the principle of delivering “the more human way to treat cancer,” the company develops patient-centric radiation therapy systems that prioritise comfort, efficiency, and accessibility. Based in Crawley, East Sussex, Leo Cancer Care’s technology portfolio includes the Marie® particle therapy system and the newly announced Grace™ photon therapy platform, designed to revolutionise how radiation therapy is delivered to cancer patients worldwide. The company recently announced its participation in the Upright Photon Alliance, a global research collaboration advancing upright radiotherapy technology.
*Please note that Leo Cancer Care solutions are currently used for research purposes only and are not yet clinically available, pending relevant regulatory approvals in the UK.*
Media Contacts:
Oncology Systems Limited
Alice Pavey, Managing Director
Tel: +44 (0)1743 462694
Email: enquiry@osl.uk.com
Web: https://osl.uk.com/
Leo Cancer Care
Sophie Towe, Director of Marketing
Email: Sophie@Leocancercare.com
Web: https://Leocancercare.com/
